Skip to main contentSkip to navigation
Sirius Investors
Electromedical Technologies, Inc.

Electromedical Technologies, Inc.

EMED
OTCHealthcare

Electromedical Technologies, Inc. (EMED) Financial Metrics

This dashboard provides comprehensive financial metrics and analysis to help evaluate Electromedical Technologies, Inc.'s investment potential. View key valuation ratios, profitability metrics, growth indicators, and historical trends to make informed investment decisions.

Financial Metrics Score

Valuation Metrics

Sector benchmarks: Industrials

2025
P/E Ratio
0.40
Strong
WeakModerateStrong
P/B Ratio
-0.16
Equity Deficit
Earnings Yield
-2.46%
Yield Gap

Profitability Health

2025
Return on Equity
39.80%
Strong
WeakModerateStrong
Operating Margin
-2468.71%
Weak
WeakModerateStrong
Net Profit Margin
-3495.26%
Weak
WeakModerateStrong

Growth Indicators

2025
Revenue Growth
-93.00%
Weak
WeakModerateStrong
Net Income Growth
-11.45%
Weak
WeakModerateStrong
EPS Growth
125.00%
Strong
WeakModerateStrong

Efficiency & Liquidity

2025
Current Ratio
0.16
Weak
WeakModerateStrong
Quick Ratio
0.16
Weak
WeakModerateStrong
Asset Turnover
0.05x
Weak
WeakModerateStrong
Inventory Turnover
4.91x
Moderate
WeakModerateStrong

Cash Flow & Resilience

Core fortress metrics for cash-rich balance sheets in high-inflation / tech-volatility regimes

2025
Free Cash Flow Yield
-25.51%
Weak
WeakModerateStrong
EV / Free Cash Flow
-9.31x
Strong
WeakModerateStrong
Net Debt / EBITDA
-0.88x
Strong
WeakModerateStrong
Interest Burden (EBT / EBIT)
1.416
Strong
WeakModerateStrong
Return on Invested Capital
42.78%
Strong
WeakModerateStrong
Cash Conversion Cycle
-1713.89 days
Strong
WeakModerateStrong

Fortress screener guardrails

3/4 passing
  • FCF Yield > 3%
  • Net Debt / EBITDA < 1.5x
  • ROIC > 20%
  • Cash Conversion Cycle < 0 days

Financial Statements

Want to see the complete financial picture? View detailed financial statements including income statements, balance sheets, and cash flow statements for EMED.

View Financial Statements